Michail Ignatiadis

18PUBLICATIONS
139CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.

|Nov 26, 2025
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

Andreas Papagiannis, Samira Majjaj, Francois P Duhoux

|Mar 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Wolfgang Janni, Thomas W P Friedl, Tracy C Yab

|Mar 07, 2025
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.

Ioannis Zerdes, Alexios Matikas, Artur Mezheyeuski

|Feb 24, 2025
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.

Matteo Lambertini, Eva Blondeaux, Loredana M Tomasello

|Nov 26, 2024
Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.

Xiaoxiao Wang, David Venet, Frédéric Lifrange

Pageof 3

Frequent Collaborators

8 joint publications

Elisa Agostinetto

8 joint publications

Christos Sotiriou

5 joint publications

Francois P Duhoux

4 joint publications

Roberto Salgado